# Peripheral Tissue Perfusion and Oxygenation in Areas at Risk of Press Ulcer (POTER-OIL)

> **NCT05144646** · NA · UNKNOWN · sponsor: **JOSE MIGUEL MORALES ASENCIO** · enrollment: 46 (estimated)

## Conditions studied

- Pressure Ulcer

## Interventions

- **OTHER:** MEPENTOL® AND FARMAOLIVA® IN HEALTHY WITH INTRASUBJECT CONTROL
- **OTHER:** MEPENTOL® AND FARMAOLIVA® IN PATIENTS WITH INTRASUBJECT CONTROL

## Key facts

- **NCT ID:** NCT05144646
- **Lead sponsor:** JOSE MIGUEL MORALES ASENCIO
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-04
- **Primary completion:** 2023-06-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144646, "Peripheral Tissue Perfusion and Oxygenation in Areas at Risk of Press Ulcer (POTER-OIL)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05144646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*